Krystal Long Term Debt Total vs Other Stockholder Equity Analysis

KRYS Stock

USD 181.96 4.48 2.52%

Krystal Biotech financial indicator trend analysis is infinitely more than just investigating Krystal Biotech recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Krystal Biotech is a good investment. Please check the relationship between Krystal Biotech Long Term Debt Total and its Other Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Krystal Stock please use our How to Invest in Krystal Biotech guide.

Long Term Debt Total vs Other Stockholder Equity

Long Term Debt Total vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Krystal Biotech Long Term Debt Total account and Other Stockholder Equity. At this time, the significance of the direction appears to have pay attention.

The correlation between Krystal Biotech's Long Term Debt Total and Other Stockholder Equity is -0.73. Overlapping area represents the amount of variation of Long Term Debt Total that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Krystal Biotech, assuming nothing else is changed. The correlation between historical values of Krystal Biotech's Long Term Debt Total and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt Total of Krystal Biotech are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Long Term Debt Total i.e., Krystal Biotech's Long Term Debt Total and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.73

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Long Term Debt Total

Other Stockholder Equity

Most indicators from Krystal Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Krystal Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Krystal Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Krystal Stock please use our How to Invest in Krystal Biotech guide.At this time, Krystal Biotech's Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 2.1 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 3.24 in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	3.0M	34.3M	5.0M	6.2M
Interest Income	197K	5.2M	22.6M	23.8M

Depreciation And Amortization Interest Income

Krystal Biotech fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Property Plant Equipment	Retained Earnings Total Equity	Net Invested Capital
Total Assets		0.81	0.84	0.99	1.0	0.77	0.99	0.96	-0.93	-0.95	0.81	0.86	0.98	0.92	0.9	-0.73	0.82	0.99	0.98	0.99	0.98	0.97	1.0	0.97	-0.95	0.93
Short Long Term Debt Total	0.81		0.57	0.85	0.81	0.76	0.85	0.76	-0.85	-0.77	0.74	0.86	0.73	0.86	0.88	-0.38	0.74	0.84	0.85	0.8	0.84	0.75	0.83	0.73	-0.86	0.81
Other Current Liab	0.84	0.57		0.85	0.84	0.56	0.78	0.9	-0.62	-0.93	0.44	0.52	0.87	0.68	0.7	-0.8	0.64	0.82	0.84	0.87	0.84	0.91	0.82	0.92	-0.74	0.73
Total Current Liabilities	0.99	0.85	0.85		0.98	0.73	0.98	0.98	-0.89	-0.97	0.81	0.83	0.98	0.91	0.91	-0.68	0.86	0.99	0.98	0.99	1.0	0.98	0.98	0.98	-0.97	0.93
Total Stockholder Equity	1.0	0.81	0.84	0.98		0.77	0.99	0.96	-0.93	-0.95	0.8	0.87	0.98	0.92	0.9	-0.73	0.82	0.99	0.98	0.99	0.98	0.96	1.0	0.97	-0.95	0.93
Other Liab	0.77	0.76	0.56	0.73	0.77		0.8	0.67	-0.85	-0.69	0.62	0.83	0.66	0.8	0.82	-0.45	0.48	0.78	0.76	0.74	0.7	0.66	0.81	0.66	-0.76	0.71
Net Tangible Assets	0.99	0.85	0.78	0.98	0.99	0.8		0.96	-0.94	-0.94	0.87	0.89	0.96	0.95	0.94	-0.63	0.86	1.0	0.97	0.98	0.98	0.95	0.99	0.95	-0.98	0.95
Property Plant And Equipment Net	0.96	0.76	0.9	0.98	0.96	0.67	0.96		-0.81	-0.99	0.78	0.75	0.99	0.87	0.87	-0.68	0.87	0.97	0.94	0.98	0.98	1.0	0.94	1.0	-0.95	0.91
Net Debt	-0.93	-0.85	-0.62	-0.89	-0.93	-0.85	-0.94	-0.81		0.8	-0.81	-0.97	-0.85	-0.92	-0.91	0.6	-0.73	-0.92	-0.93	-0.9	-0.88	-0.81	-0.95	-0.81	0.89	-0.89
Retained Earnings	-0.95	-0.77	-0.93	-0.97	-0.95	-0.69	-0.94	-0.99	0.8		-0.72	-0.74	-0.96	-0.88	-0.89	0.66	-0.86	-0.96	-0.94	-0.97	-0.97	-0.99	-0.93	-0.99	0.94	-0.91
Accounts Payable	0.81	0.74	0.44	0.81	0.8	0.62	0.87	0.78	-0.81	-0.72		0.84	0.81	0.88	0.82	-0.27	0.86	0.84	0.74	0.78	0.82	0.77	0.79	0.75	-0.9	0.87
Cash	0.86	0.86	0.52	0.83	0.87	0.83	0.89	0.75	-0.97	-0.74	0.84		0.78	0.96	0.93	-0.41	0.76	0.87	0.87	0.83	0.83	0.74	0.89	0.74	-0.87	0.91
Non Current Assets Total	0.98	0.73	0.87	0.98	0.98	0.66	0.96	0.99	-0.85	-0.96	0.81	0.78		0.88	0.85	-0.72	0.85	0.98	0.94	0.98	0.98	0.99	0.96	0.99	-0.94	0.92
Cash And Short Term Investments	0.92	0.86	0.68	0.91	0.92	0.8	0.95	0.87	-0.92	-0.88	0.88	0.96	0.88		0.98	-0.43	0.88	0.94	0.91	0.91	0.91	0.87	0.93	0.86	-0.95	0.98
Common Stock Shares Outstanding	0.9	0.88	0.7	0.91	0.9	0.82	0.94	0.87	-0.91	-0.89	0.82	0.93	0.85	0.98		-0.42	0.87	0.93	0.91	0.9	0.9	0.86	0.92	0.85	-0.95	0.95
Long Term Debt Total	-0.73	-0.38	-0.8	-0.68	-0.73	-0.45	-0.63	-0.68	0.6	0.66	-0.27	-0.41	-0.72	-0.43	-0.42		-0.32	-0.66	-0.74	-0.73	-0.67	-0.69	-0.72	-0.73	0.51	-0.48
Non Current Liabilities Total	0.82	0.74	0.64	0.86	0.82	0.48	0.86	0.87	-0.73	-0.86	0.86	0.76	0.85	0.88	0.87	-0.32		0.86	0.81	0.85	0.88	0.87	0.8	0.84	-0.91	0.92
Capital Surpluse	0.99	0.84	0.82	0.99	0.99	0.78	1.0	0.97	-0.92	-0.96	0.84	0.87	0.98	0.94	0.93	-0.66	0.86		0.98	0.99	0.99	0.97	0.99	0.97	-0.98	0.94
Other Current Assets	0.98	0.85	0.84	0.98	0.98	0.76	0.97	0.94	-0.93	-0.94	0.74	0.87	0.94	0.91	0.91	-0.74	0.81	0.98		0.98	0.97	0.94	0.99	0.95	-0.93	0.91
Other Stockholder Equity	0.99	0.8	0.87	0.99	0.99	0.74	0.98	0.98	-0.9	-0.97	0.78	0.83	0.98	0.91	0.9	-0.73	0.85	0.99	0.98		0.99	0.98	0.99	0.98	-0.95	0.93
Total Liab	0.98	0.84	0.84	1.0	0.98	0.7	0.98	0.98	-0.88	-0.97	0.82	0.83	0.98	0.91	0.9	-0.67	0.88	0.99	0.97	0.99		0.98	0.97	0.98	-0.97	0.94
Property Plant And Equipment Gross	0.97	0.75	0.91	0.98	0.96	0.66	0.95	1.0	-0.81	-0.99	0.77	0.74	0.99	0.87	0.86	-0.69	0.87	0.97	0.94	0.98	0.98		0.94	1.0	-0.94	0.91
Total Current Assets	1.0	0.83	0.82	0.98	1.0	0.81	0.99	0.94	-0.95	-0.93	0.79	0.89	0.96	0.93	0.92	-0.72	0.8	0.99	0.99	0.99	0.97	0.94		0.95	-0.95	0.93
Property Plant Equipment	0.97	0.73	0.92	0.98	0.97	0.66	0.95	1.0	-0.81	-0.99	0.75	0.74	0.99	0.86	0.85	-0.73	0.84	0.97	0.95	0.98	0.98	1.0	0.95		-0.93	0.9
Retained Earnings Total Equity	-0.95	-0.86	-0.74	-0.97	-0.95	-0.76	-0.98	-0.95	0.89	0.94	-0.9	-0.87	-0.94	-0.95	-0.95	0.51	-0.91	-0.98	-0.93	-0.95	-0.97	-0.94	-0.95	-0.93		-0.95
Net Invested Capital	0.93	0.81	0.73	0.93	0.93	0.71	0.95	0.91	-0.89	-0.91	0.87	0.91	0.92	0.98	0.95	-0.48	0.92	0.94	0.91	0.93	0.94	0.91	0.93	0.9	-0.95

Click cells to compare fundamentals

Krystal Biotech Account Relationship Matchups

Krystal Biotech fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	209.0M	310.8M	626.3M	558.5M	818.4M	859.3M
Other Current Liab	19K	26K	87K	23.3M	27.5M	28.9M
Total Current Liabilities	3.3M	15.5M	25.7M	28.8M	33.1M	34.7M
Total Stockholder Equity	202.9M	292.1M	593.6M	522.2M	778.6M	817.6M
Net Tangible Assets	202.9M	292.1M	593.6M	522.2M	600.6M	630.6M
Property Plant And Equipment Net	11.2M	34.2M	119.6M	169.7M	168.2M	176.6M
Net Debt	(184.3M)	(256.7M)	(333.2M)	(153.0M)	(350.2M)	(332.7M)
Retained Earnings	(39.0M)	(71.2M)	(140.8M)	(280.8M)	(269.8M)	(256.3M)
Accounts Payable	724K	2.1M	8.4M	4.0M	4.1M	2.8M
Cash	187.5M	268.3M	341.2M	161.9M	358.3M	202.5M
Non Current Assets Total	13.1M	35.8M	184.0M	174.7M	230.4M	242.0M
Non Currrent Assets Other	1.5M	1.6M	74K	324K	263K	249.9K
Cash And Short Term Investments	193.7M	271.3M	438.1M	379.2M	532.2M	271.9M
Common Stock Shares Outstanding	15.9M	18.8M	22.2M	25.5M	27.8M	18.0M
Liabilities And Stockholders Equity	209.0M	310.8M	626.3M	558.5M	818.4M	859.3M
Non Current Liabilities Total	2.8M	3.3M	7.0M	7.4M	6.6M	4.0M
Capital Surpluse	133.2M	242.0M	363.3M	734.5M	844.7M	886.9M
Other Current Assets	2.2M	3.8M	4.2M	4.6M	6.7M	7.0M
Other Stockholder Equity	242.0M	363.3M	734.5M	803.7M	1.0B	1.1B
Total Liab	6.1M	18.8M	32.7M	36.2M	39.7M	41.7M
Property Plant And Equipment Gross	11.2M	34.2M	123.8M	176.5M	181.1M	190.1M
Total Current Assets	195.9M	275.1M	442.3M	383.8M	587.9M	617.3M
Accumulated Other Comprehensive Income	10K	6K	(163K)	(728K)	638K	669.9K
Property Plant Equipment	11.2M	30.9M	119.6M	169.7M	195.2M	204.9M
Other Assets	1.5M	4.9M	74K	324K	372.6K	354.0K
Short Term Investments	6.2M	3.0M	96.9M	217.3M	173.9M	182.5M
Net Invested Capital	202.9M	292.1M	593.6M	522.2M	778.6M	401.1M
Net Working Capital	192.6M	259.6M	416.5M	354.9M	554.8M	304.5M

Pair Trading with Krystal Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Krystal Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Krystal Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Krystal Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Krystal Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Krystal Biotech to buy it.

The correlation of Krystal Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Krystal Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Krystal Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Krystal Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Krystal Stock Analysis

When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Krystal Long Term Debt Total vs Other Stockholder Equity Analysis

Long Term Debt Total vs Other Stockholder Equity

Long Term Debt Total vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Long Term Debt Total

Other Stockholder Equity

Krystal Biotech fundamental ratios Correlations

Krystal Biotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Krystal Biotech fundamental ratios Accounts

Pair Trading with Krystal Biotech

Additional Tools for Krystal Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Stockholder Equity
Capital Surpluse	+ 1.0	Net Tangible Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net

Property Plant Equipment	- 0.99	Retained Earnings
Property Plant And Equipment Gross	- 0.99	Retained Earnings
Retained Earnings	- 0.99	Property Plant And Equipment Net
Retained Earnings Total Equity	- 0.98	Capital Surpluse
Retained Earnings Total Equity	- 0.98	Net Tangible Assets
Retained Earnings Total Equity	- 0.97	Total Liab